Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Robotic Partial Nephrectomy versus Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.

Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH.

BJU Int. 2020 Mar 31. doi: 10.1111/bju.15064. [Epub ahead of print]

PMID:
32232920
2.

A War on Two Fronts: Cancer Care in the Time of COVID-19.

Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI.

Ann Intern Med. 2020 Mar 27. doi: 10.7326/M20-1133. [Epub ahead of print] No abstract available.

PMID:
32219410
3.

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.

Miron B, Hoffman-Censits JH, Anari F, O'Neill J, Geynisman DM, Zibelman MR, Kutikov A, Viterbo R, Greenberg RE, Chen D, Lallas CD, Trabulsi EJ, Alpaugh RK, Dulaimi E, Golemis EA, Uzzo R, Ross EA, Plimack ER.

Eur Urol Oncol. 2020 Mar 10. pii: S2588-9311(20)30028-6. doi: 10.1016/j.euo.2020.02.003. [Epub ahead of print]

PMID:
32165095
4.

The volume-outcome relationship in kidney cancer: is more really better?

Kadow BT, Joshi SS, Kutikov A, Handorf E, Smaldone MC, Uzzo RG, Geynisman DM.

Ann Transl Med. 2019 Dec;7(Suppl 8):S336. doi: 10.21037/atm.2019.09.108. No abstract available.

5.

Pathologically Node-Positive Prostate Cancer: Casting for Cure When the Die Is Cast?

Ginsburg KB, Cher ML, Kutikov A, Morgan TM.

Cancer J. 2020 Jan/Feb;26(1):58-63. doi: 10.1097/PPO.0000000000000426.

PMID:
31977387
6.

Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses.

Marchioni M, Berardinelli F, Zhang C, Simone G, Uzzo RG, Capitanio U, Minervini A, Lau C, Kaouk J, Langenstroer P, Amparore D, de Luyk N, Porter J, Gallucci M, Kutikov A, Larcher A, Mari A, Kilday P, Rha KH, Quarto G, Perdonà S, White W, Eun DD, Derweesh I, Mottrie A, Anele UA, Jacobsohn K, Porpiglia F, Challacombe B, Sundaram CP, Autorino R, Yang B, Schips L.

J Endourol. 2020 Mar;34(3):289-297. doi: 10.1089/end.2019.0604.

PMID:
31950886
7.

Extraluminal Duodenal Gangliocytic Paraganglioma Presenting with Intractable Back Pain in a Patient with End-Stage Renal Disease.

Kilcoyne M, Gauvin G, Cooley J, Nagarathinam R, Lefton M, Kutikov A, Reddy S.

J Gastrointest Cancer. 2020 Jan 15. doi: 10.1007/s12029-020-00357-4. [Epub ahead of print] No abstract available.

PMID:
31940134
8.

Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome.

Zarrabi K, Masic S, Schaefer C, Bartel MJ, Kutikov A, Zibelman M.

Urol Case Rep. 2019 Nov 25;29:101077. doi: 10.1016/j.eucr.2019.101077. eCollection 2020 Mar.

9.

Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis.

Veccia A, Antonelli A, Uzzo RG, Novara G, Kutikov A, Ficarra V, Simeone C, Mirone V, Hampton LJ, Derweesh I, Porpiglia F, Autorino R.

Eur Urol Focus. 2019 Nov 24. pii: S2405-4569(19)30345-1. doi: 10.1016/j.euf.2019.11.004. [Epub ahead of print] Review.

PMID:
31776071
10.

Reply by Authors.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A.

J Urol. 2020 Mar;203(3):503-504. doi: 10.1097/JU.0000000000000591.02. Epub 2019 Nov 27. No abstract available.

PMID:
31774733
11.

Modern Management of Kidney Cancer: Is a Chance to Cut a Chance to Cure?

Kutikov A.

Eur Urol Focus. 2019 Nov;5(6):921-922. doi: 10.1016/j.euf.2019.10.005. Epub 2019 Oct 25. No abstract available.

PMID:
31668792
12.

Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.

Nejati R, Wei S, Uzzo RG, Poureghbali S, Pei J, Talarchek JN, Ruth K, Dulaimi E, Kutikov A, Testa JR, Al-Saleem T.

Clin Genitourin Cancer. 2020 Feb;18(1):56-61. doi: 10.1016/j.clgc.2019.09.016. Epub 2019 Sep 26.

PMID:
31648964
13.

Non-contrast imaging characteristics of papillary renal cell carcinoma: implications for diagnosis and subtyping.

Badri AV, Waingankar N, Edwards K, Kutikov A, Parsons RB, Chen DY, Smaldone MC, Viterbo R, Greenberg RE, Uzzo RG.

Can J Urol. 2019 Oct;26(5):9916-9921.

PMID:
31629440
14.

Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A.

J Urol. 2020 Mar;203(3):496-504. doi: 10.1097/JU.0000000000000591. Epub 2019 Oct 14.

PMID:
31609167
15.

Is Knowledge Power or Is Ignorance Bliss: Screening and Management of Familial Renal Cell Carcinoma Syndromes.

Strother M, Kutikov A.

Eur Urol. 2019 Dec;76(6):765-766. doi: 10.1016/j.eururo.2019.07.008. Epub 2019 Jul 21. No abstract available.

PMID:
31337516
16.

Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.

Joshi SS, Handorf ER, Sienko D, Zibelman M, Uzzo RG, Kutikov A, Horwitz EM, Smaldone MC, Geynisman DM.

Eur Urol Oncol. 2020 Feb;3(1):104-111. doi: 10.1016/j.euo.2019.06.016. Epub 2019 Jul 18.

PMID:
31326500
17.

Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy.

Waingankar N, Mallin K, Egleston BL, Winchester DP, Uzzo RG, Kutikov A, Smaldone MC.

Med Care. 2019 Sep;57(9):728-733. doi: 10.1097/MLR.0000000000001143.

PMID:
31313685
18.

The Alphabet Soup of Modern Nephrometry Systems.

Srivastava A, Ficarra V, Kutikov A.

Eur Urol Oncol. 2018 Oct;1(5):435-436. doi: 10.1016/j.euo.2018.08.026. Epub 2018 Sep 24. No abstract available.

PMID:
31158084
19.

Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.

McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin M, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A.

BJU Int. 2019 Dec;124(6):999-1005. doi: 10.1111/bju.14839. Epub 2019 Jun 30.

PMID:
31145523
20.

Role of Active Surveillance for Localized Small Renal Masses.

Mir MC, Capitanio U, Bertolo R, Ouzaid I, Salagierski M, Kriegmair M, Volpe A, Jewett MAS, Kutikov A, Pierorazio PM; Young Academic Urologists Kidney Cancer working group of the European Urological Association.

Eur Urol Oncol. 2018 Aug;1(3):177-187. doi: 10.1016/j.euo.2018.05.001. Epub 2018 May 26. Review.

PMID:
31102618
21.

Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy.

Joshi SS, Ruth K, Smaldone MC, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

Kidney Cancer. 2018 Mar 30;2(1):47-55. doi: 10.3233/KCA-180031.

22.

Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group).

Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F, Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M, Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH, Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R.

World J Urol. 2019 Nov;37(11):2439-2450. doi: 10.1007/s00345-019-02657-2. Epub 2019 Feb 7.

PMID:
30734072
23.

Spontaneous resolution of a 10 cm heterogenous renal lesion upon expectant management.

Lee M, Lee Z, Kutikov A.

Urol Case Rep. 2019 Jan 14;23:85-86. doi: 10.1016/j.eucr.2019.01.008. eCollection 2019 Mar.

24.

A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.

Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP.

World J Urol. 2019 Oct;37(10):2099-2108. doi: 10.1007/s00345-019-02637-6. Epub 2019 Jan 22.

PMID:
30671637
25.

Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare?

Ahmad AE, Kutikov A, Finelli A.

Eur Urol. 2019 May;75(5):868-870. doi: 10.1016/j.eururo.2019.01.006. Epub 2019 Jan 12. No abstract available.

PMID:
30642611
26.

Incisional hernia after cystectomy: incidence, risk factors and anthropometric predisposition.

Edwards DC, Cahn DB, Reddy M, Kivlin D, Malhotra A, Li T, Chen DYT, Viterbo R, Uzzo RG, Greenberg RE, Smaldone MC, Curcillo P, Kutikov A.

Can J Urol. 2018 Dec;25(6):9573-9578.

PMID:
30553281
27.

Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumor.

Asghar AM, McIntosh AG, Kutikov A, Chen DY, Geynisman DM.

Urol Case Rep. 2018 Nov 9;23:3-5. doi: 10.1016/j.eucr.2018.11.002. eCollection 2019 Mar. No abstract available.

28.

Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study.

Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane BR.

Urol Oncol. 2019 Jan;37(1):33-39. doi: 10.1016/j.urolonc.2018.11.007. Epub 2018 Nov 23.

PMID:
30473205
29.

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER.

Eur Urol Oncol. 2018 May;1(1):54-60. doi: 10.1016/j.euo.2018.02.007. Epub 2018 Jun 6.

30.

Robotic Inferior Vena Cava Thrombectomy: Are We Entering the House Through an Attic Window?

Masic S, Kutikov A.

Eur Urol Focus. 2018 Sep;4(5):641-642. doi: 10.1016/j.euf.2018.10.012. Epub 2018 Nov 8.

PMID:
30415922
31.

The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs.

Gershman B, Bukavina L, Chen Z, Konety B, Schumache F, Li L, Kutikov A, Smaldone M, Abouassaly R, Kim SP.

Eur Urol Focus. 2020 Mar 15;6(2):305-312. doi: 10.1016/j.euf.2018.10.004. Epub 2018 Oct 22.

PMID:
30361146
32.

Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Greco F, Autorino R, Altieri V, Campbell S, Ficarra V, Gill I, Kutikov A, Mottrie A, Mirone V, van Poppel H.

Eur Urol. 2019 Mar;75(3):477-491. doi: 10.1016/j.eururo.2018.10.005. Epub 2018 Oct 13.

PMID:
30327272
33.

Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.

Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG.

Urology. 2019 Jan;123:174-180. doi: 10.1016/j.urology.2018.08.044. Epub 2018 Oct 6.

PMID:
30296503
34.

Internal decompression of the acutely contused spinal cord: Differential effects of irrigation only versus biodegradable scaffold implantation.

Guest JD, Moore SW, Aimetti AA, Kutikov AB, Santamaria AJ, Hofstetter CP, Ropper AE, Theodore N, Ulich TR, Layer RT.

Biomaterials. 2018 Dec;185:284-300. doi: 10.1016/j.biomaterials.2018.09.025. Epub 2018 Sep 19.

PMID:
30265898
35.

Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.

Bukavina L, Tilburt JC, Konety B, Shah ND, Gross CP, Yu JB, Schumacher F, Kutikov A, Smaldone MC, Kim SP.

Eur Urol Focus. 2020 Mar 15;6(2):273-279. doi: 10.1016/j.euf.2018.09.002. Epub 2018 Sep 13.

PMID:
30219709
36.

Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.

Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC.

Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.

37.

Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media.

Borgmann H, Cooperberg M, Murphy D, Loeb S, N'Dow J, Ribal MJ, Woo H, Rouprêt M, Winterbottom A, Wijburg C, Wirth M, Catto J, Kutikov A.

Eur Urol. 2018 Nov;74(5):644-650. doi: 10.1016/j.eururo.2018.08.022. Epub 2018 Sep 1. Review.

38.

Method and Apparatus for the Automated Delivery of Continuous Neural Stem Cell Trails Into the Spinal Cord of Small and Large Animals.

Kutikov AB, Moore SW, Layer RT, Podell PE, Sridhar N, Santamaria AJ, Aimetti AA, Hofstetter CP, Ulich TR, Guest JD.

Neurosurgery. 2019 Oct 1;85(4):560-573. doi: 10.1093/neuros/nyy379.

PMID:
30169668
39.

Functional Parenchymal Volume-based Spectrum Score Is Able to Quantify Ischemic Injury After Partial Nephrectomy.

Lee Z, Uzzo R, Asghar A, Parkansky P, Botejue M, Li T, Viterbo R, Chen DYT, Smaldone M, Kutikov A.

Urology. 2018 Oct;120:150-155. doi: 10.1016/j.urology.2018.07.027. Epub 2018 Jul 29.

PMID:
30063909
40.

Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer.

Kim AH, Konety B, Chen Z, Schumacher F, Kutikov A, Smaldone M, Abouassaly R, Khanna A, Kim SP.

Urology. 2018 Oct;120:173-179. doi: 10.1016/j.urology.2018.06.038. Epub 2018 Jul 7.

PMID:
29990574
41.

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.

Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM.

Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299. Review.

42.

Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.

Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM.

Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5.

PMID:
29880274
43.

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).

Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F.

Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19.

PMID:
29784191
44.

Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.

McIntosh AG, Ristau BT, Ruth K, Jennings R, Ross E, Smaldone MC, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG.

Eur Urol. 2018 Aug;74(2):157-164. doi: 10.1016/j.eururo.2018.03.011. Epub 2018 Apr 4.

PMID:
29625756
45.

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.

Makhov P, Naito S, Haifler M, Kutikov A, Boumber Y, Uzzo RG, Kolenko VM.

Cell Death Dis. 2018 Mar 7;9(3):374. doi: 10.1038/s41419-018-0388-1.

46.

Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.

Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Smaldone MC, Geynisman DM.

JAMA Oncol. 2018 May 1;4(5):643-649. doi: 10.1001/jamaoncol.2017.5608.

47.

Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy.

Haifler M, Pence I, Sun Y, Kutikov A, Uzzo RG, Mahadevan-Jansen A, Patil CA.

J Biophotonics. 2018 Jun;11(6):e201700188. doi: 10.1002/jbio.201700188. Epub 2018 May 16.

PMID:
29411949
48.

The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma.

Mehrazin R, Dulaimi E, Uzzo RG, Devarjan K, Pei J, Smaldone MC, Kutikov A, Testa JR, Al-Saleem T.

Ther Adv Urol. 2017 Oct 31;10(1):3-10. doi: 10.1177/1756287217732660. eCollection 2018 Jan.

49.

Prostate Cancer Patients' Understanding of the Gleason Scoring System: Implications for Shared Decision-Making.

Tagai EK, Miller SM, Kutikov A, Diefenbach MA, Gor RA, Al-Saleem T, Chen DYT, Fleszar S, Roy G.

J Cancer Educ. 2019 Jun;34(3):441-445. doi: 10.1007/s13187-018-1320-1.

50.

Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC.

J Urol. 2018 May;199(5):1238-1244. doi: 10.1016/j.juro.2017.11.121. Epub 2017 Dec 15.

PMID:
29248557

Supplemental Content

Loading ...
Support Center